Nieuws
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...
Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
Resultaten die mogelijk niet toegankelijk zijn voor u worden momenteel weergegeven.
Niet-toegankelijke resultaten verbergen